Neocis' Yomi gets FDA OK for new bone reduction feature

By staff writers

November 17, 2022 -- Robot-assisted dental surgery firm Neocis has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new bone reduction feature on its Yomi dental robotic system.

The new indication allows dental professionals to perform robot-guided alveoloplasty of the mandible and/or maxilla. A patient's computed tomography scan is used to digitally plan the bone reduction and placement of implants. During a procedure, Yomi's guide arm provides haptic feedback to keep the burr from deviating beyond preplanned resection boundaries.

Yomi's bone reduction functionality is expected to be commercially available in early 2023.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking